The Drug Enforcement Administration (DEA) is moving to dramatically increase the amount of certain psychedelics that can be legally produced in the U.S. next year for medical, scientific, research and industrial purposes while saying it will be issuing a separate proposal to reflect marijuana production quotas in light of the Trump administration’s rescheduling move. The […]